BACKGROUND Myocardial fibrosis is a key mechanism of left ventricular decompensation in aortic stenosis and can be quantified using cardiovascular magnetic resonance (CMR) measures such as extracellular volume fraction (ECV%).
A ortic stenosis is a disease of both the valve and myocardium. Progressive myocardial remodeling and hypertrophy occur over time in response to sustained pressure overload, decreasing wall stress, and maintaining cardiac performance. However, if untreated, this hypertrophic response eventually decompensates, and patients transition to symptomatic heart failure and adverse events (1) .
Myocardial fibrosis is a key pathological process driving left ventricular (LV) decompensation (2) . Two distinct patterns of fibrosis are observed: focal replacement fibrosis and diffuse interstitial fibrosis Several T1 mapping measures have been proposed to date to detect changes in diffuse myocardial fibrosis. Native T1 mapping produces a voxel-based map of the myocardium that estimates absolute myocardial T1 values (7) . Extracellular volume (ECV)based measures utilize extracellular gadoliniumbased contrast agents to calculate the relative (extracellular volume fraction [ECV%]) or absolute (indexed extracellular volume [iECV]) ECV of the myocardium (8, 9) . Although each measure has been validated against histology (8) (9) (10) (11) (12) (13) (14) (15) (16) , the optimal T1 mapping approach remains unclear and robust multicenter outcome data are lacking.
In the present study, we investigated CMR T1 mapping in a large international multicenter study of patients with severe aortic stenosis scheduled for aortic valve intervention. In particular, we investigated the asso- Table 1 ).
All patients underwent CMR with T1 mapping performed both before and following intravenous gadolinium contrast administration. Exclusion criteria were the presence of an implantable cardiac device, advanced renal dysfunction (estimated glomerular filtration rate <30 ml/min/1.73 m 2 ), previous valve severity, which was assessed on the basis of the peak velocity, mean gradient, and aortic valve area (17) (18) (19) .
CARDIOVASCULAR MAGNETIC RESONANCE. CMR was performed on a range of different scanners, T1 mapping pulse sequences, and field strengths (Online Table 1 ). Standard long-axis cine images were acquired as well as a short-axis cine stack of the left ventricle. Late gadolinium enhancement imaging with both a short-axis LV stack and standard longaxis views was performed 5 to 15 min following gadolinium contrast agent administration. T1 mapping data were acquired in a short-axis midventricular view of the left ventricle both before and 10 to 20 min following gadolinium contrast agent administration. Aortic valve intervention (median 15 [4, 58] days post-CMR) ECV440 Aortic Stenosis T1 Mapping 
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Cardiovascular magnetic resonance (CMR) short-axis cine images were contoured to provide ventricular volumes, mass, and ejection fraction (A). Areas of late gadolinium enhancement (B, red arrows) were quantified using the full-width-at-half-maximum technique. Native (C) and post-contrast (D) T1 maps were analyzed, and the mean value from segment 9 (shaded blue) and blood pool (orange contour) were used to calculate the extracellular volume fraction (ECV% 
RESULTS
A total of 440 patients across 10 sites in 5 countries were included in the final analysis (70 AE 10 years, 59% male) ( Figure 1) with a large proportion having hypertension (64%), diabetes mellitus (21%), and coronary heart disease (38%) ( Table 1 and Online Table 2 ).
Overall, 277 (63%) patients were imaged on 1. The mean ECV% was 27.7 AE 3.6%, with good interobserver variability (4.4 AE 3.4%, intraclass correlation coefficient ¼ 0.961). To explore associations between ECV% and clinical variables, the total cohort was divided into tertiles (tertile 1, <25.9%; tertile 2, 25.9 to 29.1%; tertile 3, >29.1%) ( Table 1) Figure 3 . progressed across the tertiles (Figure 3) . Associations with iECV on univariable analysis were similar to the tertiles analysis (Online Figure 4) . This relationship appeared numerically consistent across intervention subgroups (Online Table 12 ). ECV% remained associated with cardiovascular death when events that could not be classified due to insufficient information were also included in this endpoint (HR: 1.15; 95% CI: 1.05 to 1.26; p ¼ 0.003).
Inclusion of variables in the multivariable models was limited to prevent overfitting. In the first model, ECV% remained predictive of the primary outcome independent of age and sex (p ¼ 0.003) ( Table 3 ). In the second model, ECV% remained predictive independent of age, sex, LV ejection fraction <50%, and late gadolinium enhancement (HR: 1.10; 95% CI: 1.02 to 1.19; p ¼ 0.013) (Figure 4 ). This association remained when peak aortic-jet velocity was added to model 2 (model 3: p ¼ 0.033). Finally, ECV% was associated with outcome independent of STS-PROM There was no difference between all-cause mortality rates when the cohort was analyzed by iECV tertile (p ¼ 0.72) (Online Table 9 ) nor was iECV associated with all-cause mortality or cardiovascular death using univariable Cox regression analysis (p ¼ 0.12 and p ¼ 0.32, respectively). In aortic stenosis, prognostic T1 mapping data have been limited to single-center studies (9,30).
DISCUSSION
This international multicenter investigation is the largest study to date to our knowledge, and the first to show a strong association between ECV% and all-cause mortality in patients with aortic stenosis on both univariable and multivariable models. After correction for a variety of other well-established prognostic markers, for every 1% increase in ECV%, there was a 10% increase in risk of all-cause ECV440 Aortic Stenosis T1 Mapping
